Cargando…

Evaluating “startup readiness” for researchers: case studies of research-based startups with biopharmaceutical research topics

For research domains such as life sciences, which pursue fundamental scientific understanding and applications intended for immediate use, academic entrepreneurship has played a pivotal role in commercialization. This paper presents an evaluation method of researchers related to user-inspired fundam...

Descripción completa

Detalles Bibliográficos
Autores principales: Goji, Tomotaka, Hayashi, Yuki, Sakata, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300125/
https://www.ncbi.nlm.nih.gov/pubmed/32577559
http://dx.doi.org/10.1016/j.heliyon.2020.e04160
_version_ 1783547522388590592
author Goji, Tomotaka
Hayashi, Yuki
Sakata, Ichiro
author_facet Goji, Tomotaka
Hayashi, Yuki
Sakata, Ichiro
author_sort Goji, Tomotaka
collection PubMed
description For research domains such as life sciences, which pursue fundamental scientific understanding and applications intended for immediate use, academic entrepreneurship has played a pivotal role in commercialization. This paper presents an evaluation method of researchers related to user-inspired fundamental research, using global databases of startup finances and academic research papers of "startup readiness." Case studies of startups related to biopharmaceutical research topics suggest that the biopharmaceutical field has rich opportunities stemming from scientific research, commercialization, and entrepreneurship. This evaluation method sorts specific industry segments by which financing activities are active, and by which related growing research topics attract increased academic attention. We constructed networks of author citation and co-authorship from paper citation networks related to research topics in industry segments in the biopharmaceutical domain. Results obtained across all research topics we surveyed demonstrated that authors in the top 10% of degree centrality ranking in both networks are far more likely to be startup participants than other authors. Our computational approach might provide convenient, dynamic, global, and real-time understanding of the “startup readiness” of researchers working with research topics for which academic attention is emerging in actively financed biopharmaceutical fields.
format Online
Article
Text
id pubmed-7300125
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73001252020-06-22 Evaluating “startup readiness” for researchers: case studies of research-based startups with biopharmaceutical research topics Goji, Tomotaka Hayashi, Yuki Sakata, Ichiro Heliyon Article For research domains such as life sciences, which pursue fundamental scientific understanding and applications intended for immediate use, academic entrepreneurship has played a pivotal role in commercialization. This paper presents an evaluation method of researchers related to user-inspired fundamental research, using global databases of startup finances and academic research papers of "startup readiness." Case studies of startups related to biopharmaceutical research topics suggest that the biopharmaceutical field has rich opportunities stemming from scientific research, commercialization, and entrepreneurship. This evaluation method sorts specific industry segments by which financing activities are active, and by which related growing research topics attract increased academic attention. We constructed networks of author citation and co-authorship from paper citation networks related to research topics in industry segments in the biopharmaceutical domain. Results obtained across all research topics we surveyed demonstrated that authors in the top 10% of degree centrality ranking in both networks are far more likely to be startup participants than other authors. Our computational approach might provide convenient, dynamic, global, and real-time understanding of the “startup readiness” of researchers working with research topics for which academic attention is emerging in actively financed biopharmaceutical fields. Elsevier 2020-06-12 /pmc/articles/PMC7300125/ /pubmed/32577559 http://dx.doi.org/10.1016/j.heliyon.2020.e04160 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Goji, Tomotaka
Hayashi, Yuki
Sakata, Ichiro
Evaluating “startup readiness” for researchers: case studies of research-based startups with biopharmaceutical research topics
title Evaluating “startup readiness” for researchers: case studies of research-based startups with biopharmaceutical research topics
title_full Evaluating “startup readiness” for researchers: case studies of research-based startups with biopharmaceutical research topics
title_fullStr Evaluating “startup readiness” for researchers: case studies of research-based startups with biopharmaceutical research topics
title_full_unstemmed Evaluating “startup readiness” for researchers: case studies of research-based startups with biopharmaceutical research topics
title_short Evaluating “startup readiness” for researchers: case studies of research-based startups with biopharmaceutical research topics
title_sort evaluating “startup readiness” for researchers: case studies of research-based startups with biopharmaceutical research topics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300125/
https://www.ncbi.nlm.nih.gov/pubmed/32577559
http://dx.doi.org/10.1016/j.heliyon.2020.e04160
work_keys_str_mv AT gojitomotaka evaluatingstartupreadinessforresearcherscasestudiesofresearchbasedstartupswithbiopharmaceuticalresearchtopics
AT hayashiyuki evaluatingstartupreadinessforresearcherscasestudiesofresearchbasedstartupswithbiopharmaceuticalresearchtopics
AT sakataichiro evaluatingstartupreadinessforresearcherscasestudiesofresearchbasedstartupswithbiopharmaceuticalresearchtopics